• 1
    Prieto M, Berenguer M, Rimola A, Loinaz C, Barrios C, Clemente G, et al. Liver transplantation in Hepatitis C. A Spanish multicentre experience. Eur J Gastroenterol Hepatol 1998; 10: 771776.
  • 2
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815820.
  • 3
    Rosen HR. Hepatitis C virus in the human liver transplantation model. Clin Liver Dis 2003; 7: 107125.
  • 4
    Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayón M, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673684.
  • 5
    Rehermann B, Chang KM, McHutchinson J, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996; 98: 14321440.
  • 6
    Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, et al. Analysis of successful immune response in persons infected with hepatitis C virus. J Exp Med 2000; 191: 14991512.
  • 7
    Barrera JM, Bruguera M, Ercilla MG, Gil C, Celis R, Gil MP, et al. Persistent hepatitis C viremia after self-limiting posttransfusion hepatitis C. Hepatology 1995; 21: 639644.
  • 8
    Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999; 30: 595601.
  • 9
    McCaughan GW, Zekry A. Pathogenesis of hepatitis C virus recurrence in the liver allograft. Liver Transpl 2002; 8: S7S13.
  • 10
    Shiffman ML, Hofman CM, Thompson EB, Ferreira-Gonzalez A, Contos MJ, Koshy A, et al. Relationship between biochemical, virological and histological response during interferon treatment of chronic hepatitis C. Hepatology 1997; 26: 780785.
  • 11
    Barnes E, Harcourt G, Brown D, Lucas M, Phillips R, Dusheiko G, Klenerman P. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 2002; 36: 743754.
  • 12
    Casanovas-Taltavull T, Ramos E, Serrano T, Baliellas C, Cañas C, Casanova A, et al. Long term histological and virological follow-up of a selected group of liver transplanted patients with hepatitis C relapse who were treated with interferon-alfa and ribavirin [Abstract]. Hepatology 2002; 36(Suppl): A58.
  • 13
    Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372374.
  • 14
    Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EA, et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995; 76: 11971204.
  • 15
    Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish I, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74: 23912399.
  • 16
    Sanchez Fueyo A, Restrepo JC, Quinto L, Bruguera M, Grande L, Sanchez-Tapias JM, Rodes J. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft. Transplantation 2002; 73: 5663.
  • 17
    Berenguer M, Prieto M, Sanjuan F, Rayon JM, Martinez F, Carrasco D, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202210.
  • 18
    Prieto M, Berenguer M, Rayon JM, Cordoba J, Argüello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplant: relationship with rejection. Hepatology 1999; 29: 250256.
  • 19
    Feray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J, Casanovas T, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999; 117: 619625.
  • 20
    Feray C, Gigou M, Samuel D, Ducot B, Maisonneuve P, Reynes M, et al. Incidence of hepatitis C in patients receiving different preparations of Hepatitis B immunoglobulins after liver transplantation. Ann Intern Med 1998; 128: 810816.
  • 21
    Narayanan Menon KV, Poterucha JJ, El-Amin OM, Burgat LJ, Kremers WF, Rosen CB, et al. Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy. Liver Transpl 2002; 8: 623629.
  • 22
    Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996; 98: 706714.
  • 23
    Cramp ME, Carucci P, Rossol S, Chokshi S, Maertens G, Williams R, Naoumov NV. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut 1999; 44: 424429.
  • 24
    Del Prete G, De Carli M, Amerigogna F, Guidizi MG, Biagiotti R, Romagnani S. Human Il-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) cell clones and inhibit their antigen specific proliferation and cytokine production. J Immunol 1993; 150: 353357.
  • 25
    Guidotti LG, Chisari FV. Cytokine-induced viral purging: role in viral pathogenesis. Curr Opin Microbiol 1999; 2: 388391.
  • 26
    Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4: 2536.
  • 27
    Guidotti LG, Borrow P, Hobbs MV, Matzke B, Gresser I, Oldstone MB, Chisari FV. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci U S A 1996; 93: 45894594.
  • 28
    Guido M, Rugge M, Colombari R, Cecchetto A, Scarpa A, Cadrobbi P. Prompt hepatitis C virus suppression following hepatitis B virus superinfection in chronic untreated hepatitis C. Ital J Gastroenterol Hepatol 1998; 30: 414417.
  • 29
    Sergi C, Arnold JC, Rau W, Otto HF, Hofmann WJ. Single nucleotide insertion in the 5'-untranslated region of hepatitis C virus with clearance of the viral RNA in a liver transplant recipient during acute hepatitis B virus superinfection. Liver 2002; 22: 7982.
  • 30
    Sagnelli E, Coppola N, Messina V, DiCaprio D, Marrocco C, Marotta A, Onofrio M. HBV superinfection in hepatitis C virus chronic carriers, viral interactions, and clinical course. Hepatology 2002; 36: 12851291.
  • 31
    Wietze P, Schott P, Braun F, Mihm S, Ramadori G. Clearance of HCV-RNA in a chronic hepatitis C virus-infected patient during acute hepatitis B virus superinfection. Liver 1999; 19: 348353.
  • 32
    Rosen HR, Chou S, Corless CL, Gretch DR, Flora KD, Boudousquie A, et al. Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation 1997; 64: 721726.
  • 33
    Doughty AL, Zekry A, Spencer JD, Turhans S, Painter D, McCaugham GW. Spontaneous clearance of hepatitis C infection post-liver transplantation is associated with rapidly changing quasispecies: a single case report. Liver Transpl 2000; 6: 648653.
  • 34
    Biron F, Ponceau B, Bouhour D, Boibieux A, Verrier B, Peyramond D. Long-term safety and antiretroviral activity of hydroxyurea and didanosine in HIV infected patients. J Acquir Immune Defic Syndr 2000; 25: 329336.
  • 35
    de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 12091220.
  • 36
    Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 34443451.
  • 37
    Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997; 25: 449458.
  • 38
    Rosen HR, Hinrichs DJ, Gretch DR, Koziel MJ, Chou S, Houghton M, et al. Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology 1999; 117: 926932.